Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 111
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

Cannabinoid Hyperemesis Syndrome

Cannabinoid Hyperemesis Syndrome

 60

The enigma of maladaptation in gastric pathophysiology

The enigma of maladaptation in gastric pathophysiology

 110

An implantable system for opioid safety

An implantable system for opioid safety

 79